Alcohol Screening among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program

Jan Klimas, John Muench, Katharina Wiest, Raina Croff, Traci Rieckmann, Dennis McCarty

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Abstract: Problem alcohol use is associated with adverse health and economic outcomes, especially among people in opioid agonist treatment. Screening, brief intervention, and referral to treatment (SBIRT) are effective in reducing alcohol use; however, issues involved in SBIRT implementation among opioid agonist patients are unknown. To assess identification and treatment of alcohol use disorders, we reviewed clinical records of opioid agonist patients screened for an alcohol use disorder in a primary care clinic (n = 208) and in an opioid treatment program (n = 204) over a two-year period. In the primary care clinic, 193 (93%) buprenorphine patients completed an annual alcohol screening and six (3%) had elevated AUDIT scores. In the opioid treatment program, an alcohol abuse or dependence diagnosis was recorded for 54 (27%) methadone patients. Practitioner focus groups were completed in the primary care (n = 4 physicians) and the opioid treatment program (n = 11 counselors) to assess experience with and attitudes towards screening opioid agonist patients for alcohol use disorders. Focus groups suggested that organizational, structural, provider, patient, and community variables hindered or fostered alcohol screening. Alcohol screening is feasible among opioid agonist patients. Effective implementation, however, requires physician training and systematic changes in workflow.

Original languageEnglish (US)
Pages (from-to)65-70
Number of pages6
JournalJournal of Psychoactive Drugs
Volume47
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Opioid Analgesics
Primary Health Care
Alcohols
Therapeutics
Focus Groups
Alcoholism
Referral and Consultation
Physicians
Buprenorphine
Workflow
Methadone
Economics
Health

Keywords

  • agonist treatment
  • alcohol
  • family medicine
  • implementation
  • opioids
  • SBIRT

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychology(all)
  • Medicine(all)

Cite this

Alcohol Screening among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program. / Klimas, Jan; Muench, John; Wiest, Katharina; Croff, Raina; Rieckmann, Traci; McCarty, Dennis.

In: Journal of Psychoactive Drugs, Vol. 47, No. 1, 01.01.2015, p. 65-70.

Research output: Contribution to journalArticle

@article{e906d01af5bd440dbaca424b6a4441af,
title = "Alcohol Screening among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program",
abstract = "Abstract: Problem alcohol use is associated with adverse health and economic outcomes, especially among people in opioid agonist treatment. Screening, brief intervention, and referral to treatment (SBIRT) are effective in reducing alcohol use; however, issues involved in SBIRT implementation among opioid agonist patients are unknown. To assess identification and treatment of alcohol use disorders, we reviewed clinical records of opioid agonist patients screened for an alcohol use disorder in a primary care clinic (n = 208) and in an opioid treatment program (n = 204) over a two-year period. In the primary care clinic, 193 (93{\%}) buprenorphine patients completed an annual alcohol screening and six (3{\%}) had elevated AUDIT scores. In the opioid treatment program, an alcohol abuse or dependence diagnosis was recorded for 54 (27{\%}) methadone patients. Practitioner focus groups were completed in the primary care (n = 4 physicians) and the opioid treatment program (n = 11 counselors) to assess experience with and attitudes towards screening opioid agonist patients for alcohol use disorders. Focus groups suggested that organizational, structural, provider, patient, and community variables hindered or fostered alcohol screening. Alcohol screening is feasible among opioid agonist patients. Effective implementation, however, requires physician training and systematic changes in workflow.",
keywords = "agonist treatment, alcohol, family medicine, implementation, opioids, SBIRT",
author = "Jan Klimas and John Muench and Katharina Wiest and Raina Croff and Traci Rieckmann and Dennis McCarty",
year = "2015",
month = "1",
day = "1",
doi = "10.1080/02791072.2014.991859",
language = "English (US)",
volume = "47",
pages = "65--70",
journal = "Journal of Psychoactive Drugs",
issn = "0279-1072",
publisher = "Haight-Ashbury Publications",
number = "1",

}

TY - JOUR

T1 - Alcohol Screening among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program

AU - Klimas, Jan

AU - Muench, John

AU - Wiest, Katharina

AU - Croff, Raina

AU - Rieckmann, Traci

AU - McCarty, Dennis

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Abstract: Problem alcohol use is associated with adverse health and economic outcomes, especially among people in opioid agonist treatment. Screening, brief intervention, and referral to treatment (SBIRT) are effective in reducing alcohol use; however, issues involved in SBIRT implementation among opioid agonist patients are unknown. To assess identification and treatment of alcohol use disorders, we reviewed clinical records of opioid agonist patients screened for an alcohol use disorder in a primary care clinic (n = 208) and in an opioid treatment program (n = 204) over a two-year period. In the primary care clinic, 193 (93%) buprenorphine patients completed an annual alcohol screening and six (3%) had elevated AUDIT scores. In the opioid treatment program, an alcohol abuse or dependence diagnosis was recorded for 54 (27%) methadone patients. Practitioner focus groups were completed in the primary care (n = 4 physicians) and the opioid treatment program (n = 11 counselors) to assess experience with and attitudes towards screening opioid agonist patients for alcohol use disorders. Focus groups suggested that organizational, structural, provider, patient, and community variables hindered or fostered alcohol screening. Alcohol screening is feasible among opioid agonist patients. Effective implementation, however, requires physician training and systematic changes in workflow.

AB - Abstract: Problem alcohol use is associated with adverse health and economic outcomes, especially among people in opioid agonist treatment. Screening, brief intervention, and referral to treatment (SBIRT) are effective in reducing alcohol use; however, issues involved in SBIRT implementation among opioid agonist patients are unknown. To assess identification and treatment of alcohol use disorders, we reviewed clinical records of opioid agonist patients screened for an alcohol use disorder in a primary care clinic (n = 208) and in an opioid treatment program (n = 204) over a two-year period. In the primary care clinic, 193 (93%) buprenorphine patients completed an annual alcohol screening and six (3%) had elevated AUDIT scores. In the opioid treatment program, an alcohol abuse or dependence diagnosis was recorded for 54 (27%) methadone patients. Practitioner focus groups were completed in the primary care (n = 4 physicians) and the opioid treatment program (n = 11 counselors) to assess experience with and attitudes towards screening opioid agonist patients for alcohol use disorders. Focus groups suggested that organizational, structural, provider, patient, and community variables hindered or fostered alcohol screening. Alcohol screening is feasible among opioid agonist patients. Effective implementation, however, requires physician training and systematic changes in workflow.

KW - agonist treatment

KW - alcohol

KW - family medicine

KW - implementation

KW - opioids

KW - SBIRT

UR - http://www.scopus.com/inward/record.url?scp=84924179990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924179990&partnerID=8YFLogxK

U2 - 10.1080/02791072.2014.991859

DO - 10.1080/02791072.2014.991859

M3 - Article

C2 - 25715074

AN - SCOPUS:84924179990

VL - 47

SP - 65

EP - 70

JO - Journal of Psychoactive Drugs

JF - Journal of Psychoactive Drugs

SN - 0279-1072

IS - 1

ER -